AvanirÀò¤j¶ï35.4»õ¦¬ÁÊ
¡i©ú³ø±M°T¡j¥[¦{»sÃĤ½¥qAvanir Pharmaceuticals(¥N¸¹AVNR)«Å¥¬¡AÀò±o¤é¥»¦P·~¤j¶ï±±ªÑ¥H35.4»õ¬ü¤¸¦¬ÁÊ¡C¤j¶ï¦]¦ÓÀò±o¯«¸g¨t²Î¯e¯fªº·sÃÄ¡C
®Ú¾ÚÁ`³¡³]¦bªF¨Êªº¤j¶ï¦VÃÒ¨é¥æ©ö´£¥æªº³ø§i¡A¨CªÑAvanir¥i´«17¬ü¤¸²{ª÷¡A¸û¸ÓªÑ©P¤@ªº15¬ü¤¸¦¬¥«»ù¡A¦³·¸»ù13¢H¡C
³o¥æ©öÅý¤j¶ïÀò±oAvanir¹ï¦hºØ¯«¸g¨t²Î¯e¯fªº¤£¦P¬ãµo¶¥¬qªº·sÃÄ¡A³o¨Ç¯e¯f¥]¬A¦Ñ¤Hè§b¯g¡B©¬ª÷»¹¯g¤Î°¾ÀYµh¡C
¥Ñ©ó¤j¶ï¥Í²£ªº¥þ²y³ÌºZ¾Pºë¯«¤Àµõ¯gÃĪ«Abilifyªº±M§QÅv©ó©ú¦~©¡º¡¡A©Ò¥H¸Ó¤½¥q¥¿§V¤O´M¨D©ú¦~¥H«áªº·s¼Wªø·~°È¡C
Avanir¨â·sÃÄ°t¦X¤j¶ïµo®i
Avanir¥Í²£ªºNuedexta¤wÀòãªvÀø°²©Ê¼vÅT(PBA)¡A§Y¬O¦ôp¥Ñ¦Ñ¤Hè§b¯g¬fª÷»¹¯gµ¥¯«¸g¨t²Î¯e¯f©Ò¤ÞPªº¥¢±±úª_©M¤j¯º¡C¸Ó¤½¥q¥¿¦b¬ãµoªºAVP-786ÃÄ¡A¥Øªº¬OªvÀø¦Ñ¤Hè§b¯g¾ÉPªº¨Å韧ݡA¤w¶i¤J«á´ÁÁ{§É¸ÕÅç¡C
SMBC NikkoÃÒ¨é«O°··~¤ÀªRû¤¤´¿®Ú¤¤¿A§Î®eAvanir¨âÃÄ¡u¿W¤@µL¤G¡B¥O¤H¿³¾Ä¤Î°t¦X¤j¶ï¡v¡A¦³§U¤j¶ï¥¢¥hAbilify±M§QÅv«áªº«ùÄò¼Wªø¡C
Avanir¦¬³ø16.92¬ü¤¸¡A¤É1.92¬ü¤¸©Î12.8¢H¡C